Published • loading... • Updated
Eli Lilly (LLY) Hovers Near $1,200 as Focus Stays on $50 Obesity Drug Access
Summary by ts2.tech
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Eli Lilly (LLY) Hovers Near $1,200 as Focus Stays on $50 Obesity Drug Access
NEW YORK, July 9, 2026, 16:11 (EDT) Eli Lilly (NYSE:LLY) closed at $1,216.55, just off its all-time highs, putting its market cap around $1.09 trillion. (StockAnalysis) Lilly posted a 56% jump in first-quarter revenue, though weaker realized prices shaved 13 points off its top-line growth. (PR Newswire) Starting July 1, a Medicare GLP-1 Bridge program…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
